38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Fentanyl 100 microgram buccal tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Fentanyl 100 microgram buccal tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely lanthanum carbonate 250 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lanthanum carbonate 250 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely aspirin 975 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aspirin 975 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Paliperidone 3 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Paliperidone 3 mg prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dirithromycin 250 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dirithromycin 250 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Salicylic acid 110 mg/g cutaneous gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Salicylic acid 110 mg/g cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Benzoyl peroxide 100 mg/mL cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Some
Benzoyl peroxide 100 mg/mL cutaneous cream	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Lidocaine hydrochloride 20 mg/g cutaneous gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Lidocaine hydrochloride 20 mg/g cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Levetiracetam 100 mg/mL oral solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Levetiracetam 100 mg/mL oral solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Glyceryl trinitrate 400 microgram sublingual tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Glyceryl trinitrate 400 microgram sublingual tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Lithium succinate 80 mg/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Lithium succinate 80 mg/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely verapamil hydrochloride 8 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely verapamil hydrochloride 8 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Estradiol 600 microgram/g cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Estradiol 600 microgram/g cutaneous gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Potassium iodide 65 mg/mL oral solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Potassium iodide 65 mg/mL oral solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Fluorouracil 20 mg/mL cutaneous solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Fluorouracil 20 mg/mL cutaneous solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Morphine sulfate 4 mg/mL oral solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Morphine sulfate 4 mg/mL oral solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Neomycin 5 mg/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Neomycin 5 mg/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Desoximetasone 2.5 mg/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Desoximetasone 2.5 mg/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Adrenaline 5 mg/mL eye solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Adrenaline 5 mg/mL eye solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Tretinoin 400 microgram/g cutaneous gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Tretinoin 400 microgram/g cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Hydrocortisone valerate 2 mg/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Hydrocortisone valerate 2 mg/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Triamcinolone acetonide 250 microgram/mL cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Some
Triamcinolone acetonide 250 microgram/mL cutaneous cream	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Nystatin 100 unit/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Nystatin 100 unit/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Tetracaine hydrochloride 5 mg/mL cutaneous solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Tetracaine hydrochloride 5 mg/mL cutaneous solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Oxybutynin hydrochloride 100 mg/g cutaneous gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Oxybutynin hydrochloride 100 mg/g cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Desoximetasone 500 microgram/g cutaneous gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Desoximetasone 500 microgram/g cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely oxymetazoline hydrochloride 2.5 milligram/1 milliliter conventional release nasal spray (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely oxymetazoline hydrochloride 2.5 milligram/1 milliliter conventional release nasal spray (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Salicylic acid 60 mg/g cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Salicylic acid 60 mg/g cutaneous gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Fludroxycortide 500 microgram/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Fludroxycortide 500 microgram/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Bacitracin 500 unit/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Bacitracin 500 unit/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some

Start Previous Page 175 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
7405641000172118	één	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)
7405651000172116	1	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)